Multiple Vasostrict ANDAs Rival Eagle In Competitive Market
‘Market Is Crowded,’ Admits Peptide-Focused ANDA Sponsor Amphastar
Amphastar, Amneal and Aurobindo are among ANDA sponsors confirming USFDA approval for generic versions of Endo’s Vasostrict (vasopressin) 20 units/ml single-dose vial – as first mover Eagle Pharmaceuticals remains locked in patent-litigation proceedings with the originator.
